Mead Johnson Nutrition Company (NYSE:MJN) has an average broker rating of 2.64, which is interpreted as a Hold, as rated by 11 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 6 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 2 considers that the stock is a Sell.
Mead Johnson Nutrition Company (NYSE:MJN) : The highest short term price target forecast on Mead Johnson Nutrition Company (NYSE:MJN) is $89 and the lowest target price is $70. A total of 6 equity analysts are currently covering the company. The average price of all the analysts is $80.67 with a standard deviation of $6.89.
Company shares have received an average consensus rating of Hold for the current week Also, Brokerage firm Citigroup maintains its rating on Mead Johnson Nutrition Company (NYSE:MJN). As per the latest information, the brokerage house raises the price target to $100 per share from a prior target of $85. The shares have been rated Buy. The rating by the firm was issued on April 18, 2016.
Mead Johnson Nutrition Company (NYSE:MJN): stock turned positive on Tuesday. Though the stock opened at $84.58, the bulls momentum made the stock top out at $86.32 level for the day. The stock recorded a low of $84.45 and closed the trading day at $86.27, in the green by 2.23%. The total traded volume for the day was 2,046,423. The stock had closed at $84.39 in the previous days trading.
In an insider trading activity, The officer (SVP and President, Asia), of Mead Johnson Nutrition Co, Stratton Christoper Richard had unloaded 33,730 shares at $86.68 per share in a transaction on May 2, 2016. The total value of transaction was $2,923,716. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.